Fabtech Technologies, which provides turnkey engineering solutions to the biopharma, pharmaceutical, and healthcare sectors, has launched its ₹230.35 crore Initial Public Offering (IPO) today, September 29, 2025.
Ahead of the IPO opening, the company has raised ₹7.89 crore from anchor investors on September 26, 2025.
Fabtech Technologies IPO is a book-building issue of ₹230.35 crores, consisting entirely of a fresh issue of 1.21 crore shares.
The price band is set between ₹181 and ₹191 per share. The basis of allotment will be finalised by October 3, 2025, and the tentative listing date on BSE and NSE is October 7, 2025.
[29-September-2025 10:30:00]
Investor Category |
Subscription (Times) |
Qualified Institutional Buyers (QIBs) |
Nil |
Non-Institutional Investors |
0.02 |
Retail Individual Investors (RIIs) |
0.04 |
Employees |
0.02 |
Total |
0.02 |
The net proceeds from the fresh will be used to:
Fabtech Technologies is a globally established provider of turnkey engineering solutions to the pharmaceutical, biotechnology, and healthcare sectors. The company has a strong international presence across more than 62 countries and delivers end-to-end turnkey solutions for setting up aseptic manufacturing facilities.
Beyond full-scale turnkey projects, Fabtech also offers standalone engineering solutions, particularly in equipment procurement, supply, and logistics management.
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here